COMMUNIQUÉ DE PRESSE publié le 05/04/2024 à 00:00, il y a 5 mois 14 jours Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023 Medicure Inc. to present 2023 Year End Financial Results on April 9, 2024, focusing on pharmaceuticals and healthcare products. Conference call details provided Conference Call Pharmaceuticals Medicure Inc. Healthcare Products 2023 Year End Financial Results
COMMUNIQUÉ DE PRESSE publié le 05/12/2023 à 23:00, il y a 9 mois 13 jours Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes Medicure Inc. announces a partnership with TheracosBio through Marley Drug to distribute BRENZAVVY, a new diabetes drug, at an affordable cash price, aiming to improve patient care in the US Medicure Inc. TheracosBio BRENZAVVY Diabetes Drug Marley Drug
COMMUNIQUÉ DE PRESSE publié le 23/11/2023 à 23:00, il y a 9 mois 25 jours Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
COMMUNIQUÉ DE PRESSE publié le 21/11/2023 à 23:00, il y a 9 mois 27 jours Medicure Reports Financial Results for Quarter Ended September 30, 2023
COMMUNIQUÉ DE PRESSE publié le 30/08/2023 à 00:00, il y a 1 année Medicure Reiterates its Commitment to Providing Exceptional Access to its Branded Pitavastatin (Zypitamag) to People Living With HIV
COMMUNIQUÉ DE PRESSE publié le 29/07/2023 à 02:00, il y a 1 année 1 mois Medicure Reports Financial Results For Quarter Ended June 30, 2023
COMMUNIQUÉ DE PRESSE publié le 25/07/2023 à 01:00, il y a 1 année 1 mois Medicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023
COMMUNIQUÉ DE PRESSE publié le 26/05/2023 à 23:30, il y a 1 année 3 mois Medicure Reports Financial Results for Quarter Ended March 31, 2023
COMMUNIQUÉ DE PRESSE publié le 06/04/2023 à 23:00, il y a 1 année 5 mois Medicure Reports Financial Results for Quarter and Year Ended December 31, 2022
COMMUNIQUÉ DE PRESSE publié le 05/04/2023 à 20:00, il y a 1 année 5 mois Medicure To Present Financial Results on April 10, 2023 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2022
Publié le 18/09/2024 à 18:45, il y a 8 heures 26 minutes Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Publié le 18/09/2024 à 18:45, il y a 8 heures 26 minutes Capital increase following the allocation of free shares to EuropaCorp employees
Publié le 18/09/2024 à 17:40, il y a 9 heures 31 minutes Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.
Publié le 18/09/2024 à 23:10, il y a 4 heures 1 minute Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Publié le 18/09/2024 à 23:00, il y a 4 heures 11 minutes Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Publié le 18/09/2024 à 21:15, il y a 5 heures 56 minutes New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Publié le 18/09/2024 à 21:00, il y a 6 heures 11 minutes Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Publié le 18/09/2024 à 16:30, il y a 10 heures 41 minutes Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Publié le 18/09/2024 à 19:11, il y a 8 heures EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Publié le 18/09/2024 à 18:45, il y a 8 heures 26 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 18/09/2024 à 18:31, il y a 8 heures 40 minutes EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Publié le 18/09/2024 à 18:13, il y a 8 heures 58 minutes BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Publié le 18/09/2024 à 17:21, il y a 9 heures 50 minutes EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share